Showing 21-30 of 216 results for "".
The Landscape of Vitiligo Treatment
https://practicaldermatology.com/series/updates-vitiligo/the-landscape-of-vitiligo-treatment/24467/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, talks with Lawrence Green, MD, a dermatologist practicing in Rockville, MD, about the landscape of treatments for patients with vitiligo and new therapies that may be coming from ongoing clinical trials.Embracing Photodynamic Therapy (PDT) in Your Practice
https://practicaldermatology.com/series/pdt-in-practice/embracing-photodynamic-therapy-pdt-in-your-practice/20209/Dr. Neal Bhatia, Chief Medical Editor of Practical Dermatology, provides updates in photodynamic therapy (PDT) and how to incorporate its techniques and technologies into everyday practice. Dr. Bhatia also provides some practical advice on using the therapy and on protecting yourself and your patienHilary Baldwin, MD: Perspective on the FDA Citizen's Petition for Acne Products with Benzoyl Peroxide (BPO)
https://practicaldermatology.com/topics/acne-rosacea/hilary-baldwin-md-perspective-fda-citizens-petition-acne-products-benzoyl-peroxide-bpo/24171/Neal Bhatia, MD, chief medical editor of Practical Dermatology® talks to Hilary E. Baldwin, MD about a new report from an independent laboratory that finds benzene can form at unacceptably high levels in both over-the-counter and prescription medications that contain benzoyl peroxide.Valeant Business Update; Melanoma Drugs Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-valeant-business-update-melanoma-drugs-approved/18679/In this edition of DermWireTV from the editors of Practical Dermatology® magazine and DermWire.com, we take a look at Valeant's warning of disruption of dermatology business following its break from specialty pharmacy Philidor. Plus, an update on Melanoma Therapeutics, including approvals of ImlygicOnexton Approved for Acne, Bellafill Debuts
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-onexton-approved-for-acne-bellafill-debuts/19019/In this edition of DermWireTV, from the editors of Practical Dermatology® magazine: Onexton is Valeant's fourth new approval in a year. We look at Suneva's renamed filler and the FDA's decision to grant breakthrough status to investigational atopic dermatitis treatment dupilumab. PLUS: This week'sExciting Developments in Treating Pediatric Dermatology
https://practicaldermatology.com/conferences/maui-derm-2024/exciting-developments-in-treating-pediatric-dermatology/20246/Chief Medical Editor Neal Bhatia, MD and Lawrence Eichenfield, MD, discuss the range of therapies currently approved or in the pipeline for atopic dermatitis, pruritus, pediatric acne--and the importance of messaging on TikTok.DermWireTV: The Year in Review - 2023!
https://practicaldermatology.com/topics/psoriasis/dermwiretv-the-year-in-review-2023/20229/Practical Dermatology® Co-Chief Medical Editor, Joel Schlessinger, MD, shares his thoughts on some of the best products and approvals of 2023 as well as the potential of new JAK inhibitors to treat alopecia areata, vitiligo, psoriasis, and atopic dermatitis. Our new contributor, Andrew Mastro, PA, tIs Your Sunscreen Safe?
https://practicaldermatology.com/conferences/scale-2023/is-your-sunscreen-safe/20187/Practical Dermatology magazine's newest editorial advisory board member Christopher Bunick, MD, PhD, shares advice on how to choose benzene-free sunscreens and offers tips on making smarter choices about sun protection.Summer AAD Highlights, Alopecia Areata Discovery
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-summer-aad-highlights-alopecia-areata-discovery/18846/In this edition of DermWireTV from the editors of Practical Dermatology® magazine and DermWire.com, new research that suggests emerging biologic therapies could help treat alopecia areata. Plus, updates on atopic dermatitis and eczema, hands-on education, and Kybella from the AAD Summer meeting. AndMomGenes, Sernivo Approval, Industry Roundup
https://practicaldermatology.com/topics/psoriasis/dermwiretv-momgenes-sernivo-approval-industry-roundup/18613/In this edition of DermWireTV, from the editors of DermWire.com and Practical Dermatology® magazine, new research gives an up-close-and-personal view of how antiperspirant affects our microbiome. Galderma's new MomGenes campaign aims to change the way mothers and daughters talk about facial aging. T